Therapeutic Management of Periodontitis and Clinical Manifestations of Rheumatoid Arthritis (ESPERA)
Efficacy of Therapeutic Management of Periodontitis on the Clinical Manifestations of Rheumatoid Arthritis: the Randomized, Controlled ESPERA Trial.
Sponsor: University Hospital, Toulouse
This NA trial investigates Periodontitis and Rheumatoid Arthritis and is currently completed. University Hospital, Toulouse leads this study, which shows 8 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Jan 2026 — Present [monthly]
Completed NA
-
Sep 2024 — Jan 2026 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2019 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2019 [monthly]
Recruiting NA
-
Mar 2017 — Jun 2018 [monthly]
Recruiting NA
Phase: PHASE2_PHASE3 → NA
-
Jan 2017 — Mar 2017 [monthly]
Recruiting PHASE2_PHASE3
First recorded
Nov 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Toulouse
For direct contact, visit the study record on ClinicalTrials.gov .